CD44 and breast carcinoma: In addition, to determine whether HV cells over-express markers associated with what some propose to be the ‘cancer stem cell state', we assessed the expression levels of breast cancer stem cell markers CD44 and CD24 by flow cytometry and observed no difference between HV and LV subpopulations for these markers (Supplementary Fig. 2d–f).